Authors
Eric Pujade-Lauraine, Felix Hilpert, Béatrice Weber, Alexander Reuss, Andres Poveda, Gunnar Kristensen, Roberto Sorio, IB Vergote, Petronella Witteveen, A Bamias
Publication date
2012/6/1
Journal
J Clin Oncol
Volume
30
Pages
327s
Description
• Bevacizumab (BEV) significantly improves progression-free survival (PFS) when combined with chemotherapy and continued as a single agent in the:
Total citations
20122013201420152016201720182019202020212022202320242089471912108553761